India axes exports of Gilead Sciences' remdesivir, plots boost to local production as...

Discussion in 'Pharma/Biotech Companies - In the News' started by cafead, Apr 12, 2021 at 11:22 PM.

  1. cafead

    cafead Administrator
    Staff Member

    Joined:
    Nov 21, 2001
    Messages:
    32,746
    Likes Received:
    3
    via India is one of the world's biggest manufacturers of drugs and vaccines, but that hasn't made it immune to COVID-19 supply instability. Now, the government is locking up at least one treatment for itself.

    As COVID-19 cases mount—and demand for treatments spikes—India has banned exports of Gilead Sciences’ pandemic antiviral remdesivir, Bloomberg reports, citing a statement put out by the country’s health ministry Sunday. The news comes as local pharmas seek an emergency nod from the country's drug regulator to manufacture remdesivir off-license, according to Times of India.

    article source